Effects of glutamate receptor antagonists on posthypoxic myoclonus in rats

Brain Research Bulletin

Volumn 40, Issue 3, 1996, Pages 163-166

  Jaw, S P ^a   Nguyen, B ^a   Vuong, Q T V ^a   Trinh, T A ^a   Nguyen, M ^a   Truong, D D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glutamate receptor antagonists; Hypoxia; Ischemia; Posthypoxic myoclonus

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 3 PHOSPHONOPROPIONIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; DIZOCILPINE; DIZOCILPINE MALEATE; GLUTAMATE RECEPTOR ANTAGONIST; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; HEART ARREST; HYPOXIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYOCLONUS; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION;

EID: 0030013902     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00053-6     Document Type: Article

References (29)

1. Anderson, K. J.; Nellgard, B.; Wieloch, T. Ischemia-induced upregulation of excitatory amino acid transport sites, Brain Res. 622:93-98; 1993.
2. Arvin, B.; Moncada, C.; Le Peillet, E.; Chapman, A. Meldrum, B. S. GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia. Neuroreport 3:235-238; 1992.
3. Bruno, V.; Copani, A.; Battaglia, G.; Raffaele, R.; Shinozaki, H.; Nicoletti, F. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur. J. Pharmacol. 256:109-112; 1994.
4. Chapman, A. G.; Smith, S. E.; Meldrum, B. S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 9:82-96; 1991.
5. Choi, D. W.; Rothman, S. M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:171-182; 1990.
6. Cotman, C. W.; Monaghan, D. T.; Ottersen, O. P.; Storm - Mathisen, J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10:273-280; 1987.
7. Fahn, S. Posthypoxic action myoclonus: Literature review update. Adv. Neurol. 43:157-169; 1986.
8. Fahn, S.; Marsden, D.; van Woert, M. H. Definition and classification of myoclonus. Adv. Neurol. 43:1-5; 1986.
9. Giordano, M.; Ford, L. M.; Brauckmann, J. L.; Norman, A. B.; Sandberg, P. R. MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum. Brain Res. Bull. 24:313-319; 1990.
10. Globus, M. Y.-T.; Busto, R.; Dietrich, W. D.; Martinez, E.; Valdes, L.; Ginsberg, M. D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1455-1464; 1988.
11. Himori, N.; Moreau, J. L.; Martin, J. R. Cerebral ischemia decreases the behavioral effects and mortality rate elicited by activation of NMDA receptors in mice. Neuropharmacol. 30:1179-1186; 1991.
12. 1A agonists attenuate posthypoxic myoclonus in rats. Pharmacol. Biochem. Behav. 52:577-580; 1995.
13. 2 receptors in posthypoxic stimulus-sensitive myoclonus in rats. Pharmacol. Biochem. Behav. 49:129-131; 1994.
14. Jaw, S. P.; Nguyen, B.; Vuong, Q.-T. V.; Trinh, T. A.; Nguyen, M.; Truong, D. D. Effects of GABA uptake inhibitors on posthypoxic myoclonus in rats. Brain Res. Bull, (in press).
15. Jaw, S. P.; Su, D. D.; Matsumoto, R. R.; Truong, D. D. Alterations of brain levels of phosphoinositidase C-linked Gq/G11 proteins and motor function in rats after cardiac arrest. Stroke 26:1067-1071; 1995.
16. Jaw, S. P.; Su, D. D.; Truong, D. D. Expression of Bcl-2 and Bax in the frontoparietal cortex of the rat following cardiac arrest. Brain Res. Bull. 38:577-580; 1995.
17. Jaw, S. P.; Su, D. D.; Truong, D. D. Astrocyte-derived growth factor (S100β) and motor function in rats following cardiac arrest. Pharmacol. Biochem. Behav. 52:667-670; 1995.
18. Lance, J. W.; Adams, R. D. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86:111-136; 1963.
19. Laudrup, P.; Klitgaard, H. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice. Eur. J. Pharmacol. 250:15-22; 1993.
20. Le Peillet, E.; Arvin, B.; Moncada, C.; Meldrum, B. S. The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res. 571:115-120; 1992.
21. Miller, L. P.; Lyeth, B. G.; Jenkins, L. W.; Oleniak, L.; Panchision. D.; Hamm, R. J.; Phillips, L. L.; Dixon, C. E.; Clifton, G. L.; Hayes, R. L. Excitatory amino acid receptor subtype binding following traumatic brain injury. Brain Res. 526:103-107; 1990.
22. 2+-deficient mice. Eur. J. Pharmacol. 204:29-34; 1991.
23. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press; 1986.
24. Pranzatelli, M. R. Antimyoclonic effect of MK-801: A possible role for NMDA receptors in developmental myoclonus of the neonatal rat. Clinical Neurophramacol. 13:329-338; 1990.
25. Saito, K.; Nowak, T. S. J.; Markey, S. P.; Heyes, M. P. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:180-192; 1992.
26. Schoepp, D. D.; Conn, P. J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14:13-19; 1993.
27. Smith, S. E.; Dürmüller, N.; Meldrum, B. S. The non-N-methyl-D aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201:179-183; 1991.
28. Turski, W. A.; Urbanska, E.; Dziki, M.; Parada - Turska, J.; Ikonomidou, C. Excitatory amino acid antagonists protect mice against seizures induced by bicuculline. Brain Res. 51:131-134; 1990.
29. Yamaguchi, S.-I.; Donevan, S. D.; Rogawski, M. A. Anticonvulsant activity of AMPA/kainate antagonists: Comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 15:179-184.